首页> 美国卫生研究院文献>Nature Communications >Multidirectional desymmetrization of pluripotent building block en route to diastereoselective synthesis of complex nature-inspired scaffolds
【2h】

Multidirectional desymmetrization of pluripotent building block en route to diastereoselective synthesis of complex nature-inspired scaffolds

机译:多能构建基团的多向去对称化以非对映选择性合成复杂的受自然启发的支架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Octahydroindolo[2,3-a]quinolizine ring system forms the basic framework comprised of more than 2000 distinct family members of natural products. Despite the potential applications of this privileged substructure in drug discovery, efficient, atom-economic and modular strategies for its assembly, is underdeveloped. Here we show a one-step build/couple/pair strategy that uniquely allows access to diverse octahydroindolo[2,3-a]quinolizine scaffolds with more than three contiguous chiral centers and broad distribution of molecular shapes via desymmetrization of the oxidative-dearomatization products of phenols. The cascade demonstrates excellent diastereoselectivity, and the enantioselectivity exceeded 99% when amino acids are used as chiral reagents. Furthermore, two diastereoselective reactions for the synthesis of oxocanes and piperazinones, is reported. Phenotypic screening of the octahydroindolo[2,3-a]quinolizine library identifies small molecule probes that selectively suppress mitochondrial membrane potential, ATP contents and elevate the ROS contents in hepatoma cells (Hepa1–6) without altering the immunological activation or reprogramming of T- and B-cells, a promising approach to cancer therapy.
机译:八氢吲哚并[2,3-a]喹诺嗪环系统形成了基本框架,该框架由2000多个天然产物的不同家族成员组成。尽管这种特权子结构在药物发现中有潜在的应用,但其组装的有效,原子经济和模块化策略仍未得到开发。在这里,我们展示了一种一步构建/偶联/配对策略,该策略独特地允许访问具有三个以上连续手性中心且通过氧化脱芳构化产物的脱对称化而分布的分子形状广泛分布的八氢吲哚并[2,3-a]喹诺嗪支架酚。级联显示出优异的非对映选择性,当氨基酸用作手性试剂时,对映选择性超过99%。此外,据报道,有两种非对映选择性反应用于合成恶唑酮和哌嗪酮。八氢吲哚并[2,3-a]喹诺嗪文库的表型筛选可鉴定出可选择性抑制线粒体膜电位,ATP含量并提高肝癌细胞(Hepa1–6)中ROS含量的小分子探针,而不会改变T-的免疫激活或重新编程和B细胞,一种有前途的癌症治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号